{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:37:03Z","timestamp":1783445823116,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010098","name":"Shanghai Association for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011470","name":"Shanghai Minhang Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biocel.2020.105820","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T01:47:45Z","timestamp":1596332865000},"page":"105820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Valproic acid overcomes sorafenib resistance by reducing the migration of Jagged2-mediated Notch1 signaling pathway in hepatocellular carcinoma cells"],"prefix":"10.1016","volume":"126","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-1621","authenticated-orcid":false,"given":"Guangchun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2020.105820_bib0005","article-title":"Inhibition of Notch signaling by a gamma-secretase inhibitor attenuates hepatic fibrosis in rats","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2020.105820_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.06.019","article-title":"Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma","volume":"367","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biocel.2020.105820_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2020.105820_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185088","article-title":"Activation of phosphatidylinositol 3-kinase\/AKT\/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells","volume":"12","author":"Dong","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2020.105820_bib0025","first-page":"21","article-title":"Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in Cancer","author":"Du","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biocel.2020.105820_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-9966-32-26","article-title":"Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of gamma-secretase in renal carcinoma","volume":"32","author":"Guo","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biocel.2020.105820_bib0035","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.7150\/jca.31448","article-title":"KPNA3 confers sorafenib resistance to advanced hepatocellular carcinoma via TWIST regulated epithelial-mesenchymal transition","volume":"10","author":"Hu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.biocel.2020.105820_bib0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003495-200969020-00006","article-title":"Sorafenib a review of its use in advanced hepatocellular carcinoma","volume":"69","author":"Keating","year":"2009","journal-title":"Drugs."},{"key":"10.1016\/j.biocel.2020.105820_bib0045","article-title":"The expression profile of Jagged1 and Delta-like 4 in hepatocellular carcinoma","author":"Kunanopparat","year":"2019","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.biocel.2020.105820_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-015-2020-4","article-title":"Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4","volume":"142","author":"Lan","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biocel.2020.105820_bib0055","first-page":"2160","article-title":"Gastric cancer cell growth and epithelial\u2011mesenchymal transition are inhibited by \u03b3\u2011secretase inhibitor","volume":"7","author":"Li","year":"2014","journal-title":"DAPT"},{"key":"10.1016\/j.biocel.2020.105820_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12480","article-title":"A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo","volume":"51","author":"Li","year":"2018","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biocel.2020.105820_bib0065","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2020.105820_bib0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2011.11.018","article-title":"IKKalpha activation of NOTCH links tumorigenesis via FOXA2 suppression","volume":"45","author":"Liu","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biocel.2020.105820_bib0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biocel.2020.105820_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117343","article-title":"Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo","volume":"244","author":"Lu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biocel.2020.105820_bib0085","first-page":"1299","article-title":"Valproic acid overcomes transforming growth factor-beta-mediated sorafenib resistance in hepatocellular carcinoma","volume":"7","author":"Matsuda","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biocel.2020.105820_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.soc.2013.10.006","article-title":"Hepatocellular carcinoma: diagnosis, management, and prognosis","volume":"23","author":"Page","year":"2014","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.biocel.2020.105820_bib0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2015.05.004","article-title":"The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro","volume":"364","author":"Piskareva","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biocel.2020.105820_bib0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/onc.2016.221","article-title":"KRT19 directly interacts with beta-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties","volume":"36","author":"Saha","year":"2017","journal-title":"Oncogene."},{"key":"10.1016\/j.biocel.2020.105820_bib0105","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7150\/jca.12135","article-title":"The histone deacetylase inhibitor vaproic acid induces cell growth arrest in hepatocellular carcinoma cells via suppressing notch signaling","volume":"6","author":"Sun","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.biocel.2020.105820_bib0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13046-017-0647-5","article-title":"Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53","volume":"36","author":"Terranova-Barberio","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biocel.2020.105820_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2017.08.002","article-title":"Valproic acid sensitizes breast cancer cells to hydroxyurea through inhibiting RPA2 hyperphosphorylation-mediated DNA repair pathway","volume":"58","author":"Tian","year":"2017","journal-title":"DNA Repair (Amst)."},{"key":"10.1016\/j.biocel.2020.105820_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2017.08.002","article-title":"Valproic acid sensitizes breast cancer cells to hydroxyurea through inhibiting RPA2 hyperphosphorylation-mediated DNA repair pathway","volume":"58","author":"Tian","year":"2017","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.biocel.2020.105820_bib0125","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biocel.2020.105820_bib0130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.suronc.2018.07.015","article-title":"Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective","volume":"27","author":"Tsilimigras","year":"2018","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.biocel.2020.105820_bib0135","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11523-015-0370-0","article-title":"The histone deacetylase inhibitor valproic acid sensitizes gemcitabine-induced cytotoxicity in gemcitabine-resistant pancreatic Cancer cells possibly through inhibition of the DNA repair protein Gamma-H2AX","volume":"10","author":"Wang","year":"2015","journal-title":"Target. Oncol."},{"key":"10.1016\/j.biocel.2020.105820_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40880-017-0203-x","article-title":"Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling","volume":"36","author":"Wang","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.biocel.2020.105820_bib0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12885-018-4344-3","article-title":"Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal","volume":"18","author":"Wei","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biocel.2020.105820_bib0150","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1016\/j.ejca.2013.07.007","article-title":"Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo","volume":"49","author":"Xie","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biocel.2020.105820_bib0155","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1158\/0008-5472.CAN-18-3750","article-title":"SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model","volume":"79","author":"Xu","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2020.105820_bib0160","doi-asserted-by":"crossref","first-page":"34996","DOI":"10.18632\/oncotarget.26209","article-title":"Synergistic antitumor effect of a gamma-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma","volume":"9","author":"Yang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biocel.2020.105820_bib0165","article-title":"Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer","author":"Yochum","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2020.105820_bib0170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3892\/mmr.2014.2246","article-title":"Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biocel.2020.105820_bib0175","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1159\/000447912","article-title":"Valproic acid promotes human glioma U87 cells apoptosis and inhibits glycogen synthase Kinase-3beta through ERK\/Akt signaling","volume":"39","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biocel.2020.105820_bib0180","doi-asserted-by":"crossref","first-page":"e2201","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biocel.2020.105820_bib0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41419-018-0804-6","article-title":"Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biocel.2020.105820_bib0190","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13046-019-1382-x","article-title":"An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biocel.2020.105820_bib0195","first-page":"2503","article-title":"Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt","volume":"7","author":"Zhu","year":"2017","journal-title":"Am. J. Cancer Res."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272520301370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272520301370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:17:19Z","timestamp":1761203839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272520301370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S1357272520301370"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2020.105820","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid overcomes sorafenib resistance by reducing the migration of Jagged2-mediated Notch1 signaling pathway in hepatocellular carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2020.105820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105820"}}